Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the beta cell function, pharmacodynamics, pharmacokinetics, safety and
tolerability after 4 weeks treatment of 75mgBID or 75mgQD of HMS5552.